MARKET

MEDP

MEDP

Medpace Holdings
NASDAQ

Real-time Quotes | Nasdaq Last Sale

159.02
-2.09
-1.30%
After Hours: 159.02 0 0.00% 16:55 02/25 EST
OPEN
161.60
PREV CLOSE
161.11
HIGH
162.49
LOW
158.51
VOLUME
213.89K
TURNOVER
--
52 WEEK HIGH
177.12
52 WEEK LOW
58.72
MARKET CAP
5.68B
P/E (TTM)
41.40
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Contract Research Organization (CRO) Market Size 2021: By Share, Application, Leading Players Update, Region, Market Estimate, Project Economics, Pricing Analysis, Opportunities and Forecast 2026
Feb 22, 2021 (The Expresswire) -- In 2021,Contract Research Organization (CRO) Market “Size, Trend, Analysis, growth, Trend, Analysis, growth, Status and...
The Express Wire · 4d ago
Medpace Holdings (MEDP) Gets a Hold Rating from Robert W. Baird
Robert W. Baird analyst Eric Coldwell maintained a Hold rating on Medpace Holdings (MEDP) on February 16. The company's shares closed last Thursday at
SmarterAnalyst · 02/18 18:00
China Contract Research Organization (CRO) Market: Demand, Upcoming Trends, Key Country Analysis and 2024 Business Overview
The Express Wire · 02/18 12:08
DJ Medpace Holdings Price Target Raised to $180.00/Share From $135.00 by Truist Securities
Dow Jones · 02/17 17:35
DJ Medpace Holdings Is Maintained at Buy by Truist Securities
Dow Jones · 02/17 17:35
--Analyst Actions: Truist Adjusts Price Target on Medpace Holdings to $180 From $135, Reiterates Buy Rating
MT Newswires · 02/17 11:55
China Contract Research Organization (CRO) Market Size, Growth, Trends and Global Segments Analysis Report
Japan, Japan, Wed, 17 Feb 2021 01:02:21 / Comserve Inc. / -- China Contract Research Organization (CRO) Market : Incredible Possibilities, Growth With...
Comserve · 02/17 06:04
10-K: MEDPACE HOLDINGS, INC.
(EDGAR Online via COMTEX) -- Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations You should read the following...
Edgar Online - (EDG = 10Q, 10K) · 02/16 21:20
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MEDP. Analyze the recent business situations of Medpace Holdings through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MEDP stock price target is 164.50 with a high estimate of 180.00 and a low estimate of 149.00.
EPS
Institutional Holdings
Institutions: 462
Institutional Holdings: 29.52M
% Owned: 82.62%
Shares Outstanding: 35.73M
TypeInstitutionsShares
Increased
110
2.41M
New
74
189.58K
Decreased
112
2.15M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.53%
Pharmaceuticals & Medical Research
-1.34%
Key Executives
Chairman/President/Chief Executive Officer/Director
August Troendle
Chief Financial Officer
Jesse Geiger
Executive Vice President
Susan Burwig
General Counsel/Secretary
Stephen Ewald
Lead Director/Independent Director
Fred Davenport
Independent Director
Brian Carley
Independent Director
Ashley Keating
Independent Director
Thomas King
Independent Director
Robert Kraft
Independent Director
Cornelius McCarthy
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
About MEDP
Medpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.

Webull offers kinds of Medpace Holdings Inc stock information, including NASDAQ:MEDP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MEDP stock methods without spending real money on the virtual paper trading platform.